Perfusion Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
268 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5918265

The global perfusion bioreactors market is experiencing a significant surge, with a reported revenue of US$ 380 million in 2024. According to market insights, this thriving industry is anticipated to reaching an impressive US$ 705 million by the end of 2031.

Perfusion Bioreactors: The Future of Bioprocessing

Bioprocessing is witnessing a transformation driven by increasing consumer demands for more efficient, cost-effective, and high-production products. The next wave of innovation in bioprocessing is being ushered in by perfusion bioreactor technologies. With their ability to outperform fed-batch bioprocessing in terms of manufacturing speed, productivity, and capital requirements, perfusion bioreactors are poised to revolutionize the industry.

Advancements in Commercial-Scale and Clinical Bioreactor Technology

Recent advancements, particularly in single-use bioreactor systems, have fueled the adoption of perfusion bioreactors in the production of commercial biopharmaceuticals. Regulatory agencies' emphasis on process analytical technologies and quality-by-design principles has further spurred innovation, enhancing the quality of biopharmaceuticals.

Market Consolidation through Mergers, Acquisitions, and Expansion

Leading companies are actively pursuing mergers, acquisitions, and expansion strategies to consolidate their positions in the market. Efforts to upgrade manufacturing facilities are a testament to the industry's commitment to growth and innovation.

Factors Driving Market Expansion

“Increasing Growth in Biopharmaceutical Production and Increasing Investments in R&D”

The global biopharmaceutical industry's growing need for high-quality bioprocesses is a key driver of the perfusion bioreactors market. As biopharmaceuticals continue to gain importance in healthcare, the demand for advanced bioprocessing technologies is on the rise.

Challenges: High Costs and Skilled Workforce

“High Cost of Equipment Hampering Market Growth”

The cost of perfusion bioreactor equipment, driven by rising demand and raw material costs, remains a significant challenge. This cost factor may limit market penetration in emerging and low-income nations.

Additionally, the installation and operation of advanced equipment require a skilled workforce with technical expertise. The shortage of experienced workers and instrument operating knowledge in the biopharmaceutical industry could potentially hinder market growth.

Booming U.S. Market

“Developed Healthcare Infrastructure in the U.S.”

The United States is experiencing a surge in the perfusion bioreactors market, driven by the use of CMO/CDMO services and government funding for clinical research. The country's developed healthcare infrastructure further supports the demand for perfusion bioreactors.

China: A Growing Market

“Increasing Investment in R&D”

China's large population and the potential for growth in emerging economies have positioned the country as a prominent market for perfusion bioreactors. Major pharmaceutical industry players are eyeing opportunities in developing nations like China.

India's Lucrative Market Potential

“Increasing Healthcare Spending”

India's increasing wealth, improved access to healthcare services, changing lifestyles, and rising demand for high-quality healthcare are contributing factors to the growing perfusion bioreactors market in the country.

Competitive Landscape

The perfusion bioreactors market is characterized by its consolidation, with major players leading the industry. Market participants are actively expanding their global reach through product launches, acquisitions, and distribution channel expansions.

Key Companies Profiled:

Sartorius AG
Cell Culture Company
Cytiva (Danaher Corporation)
CELLEC BIOTEK AG
Synthecon Inc
Getinge (Applikon Biotechnology B.V)
Zellwerk GmbH
Thermo Fisher Scientific Inc
Eppendorf AG
Infors HT
3D Biotek LLC

As the global perfusion bioreactors market continues to evolve, these companies are at the forefront of innovation, shaping the future of bioprocessing.

Market Segmentation

By Scale:

Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
Large Scale Perfusion Bioreactors (> 1,000 Litres)

By Application:

Perfusion Bioreactors for R&D
Perfusion Bioreactors for GMP

By End User:

Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organization (CRO)
Contract Manufacturing Organization (CMO)

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

This product will be delivered within 1-3 business days.

1. Executive Summary
1.1. Global Perfusion Bioreactors Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Perfusion Bioreactors Market Outlook, 2018 - 2031
3.1. Global Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
3.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
3.2. Global Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Perfusion Bioreactors for R&D
3.2.1.2. Perfusion Bioreactors for GMP
3.3. Global Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Biopharmaceutical Companies
3.3.1.2. Academic and Research Institutes
3.3.1.3. Contract Research Organization (CRO)
3.3.1.4. Contract Manufacturing Organization (CMO)
3.4. Global Perfusion Bioreactors Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa

4. North America Perfusion Bioreactors Market Outlook, 2018 - 2031
4.1. North America Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
4.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
4.2. North America Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Perfusion Bioreactors for R&D
4.2.1.2. Perfusion Bioreactors for GMP
4.3. North America Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Biopharmaceutical Companies
4.3.1.2. Academic and Research Institutes
4.3.1.3. Contract Research Organization (CRO)
4.3.1.4. Contract Manufacturing Organization (CMO)
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Perfusion Bioreactors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1.2. U.S. Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1.3. U.S. Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1.4. Canada Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1.5. Canada Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.1.6. Canada Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Perfusion Bioreactors Market Outlook, 2018 - 2031
5.1. Europe Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
5.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
5.2. Europe Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Perfusion Bioreactors for R&D
5.2.1.2. Perfusion Bioreactors for GMP
5.3. Europe Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Biopharmaceutical Companies
5.3.1.2. Academic and Research Institutes
5.3.1.3. Contract Research Organization (CRO)
5.3.1.4. Contract Manufacturing Organization (CMO)
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Perfusion Bioreactors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.2. Germany Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.3. Germany Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.4. U.K. Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.5. U.K. Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.6. U.K. Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.7. France Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.8. France Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.9. France Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.10. Italy Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.11. Italy Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.12. Italy Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.13. Turkey Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.14. Turkey Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.15. Turkey Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.16. Russia Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.17. Russia Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.18. Russia Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.19. Rest of Europe Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.20. Rest of Europe Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.1.21. Rest of Europe Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Perfusion Bioreactors Market Outlook, 2018 - 2031
6.1. Asia Pacific Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
6.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
6.2. Asia Pacific Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Perfusion Bioreactors for R&D
6.2.1.2. Perfusion Bioreactors for GMP
6.3. Asia Pacific Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Biopharmaceutical Companies
6.3.1.2. Academic and Research Institutes
6.3.1.3. Contract Research Organization (CRO)
6.3.1.4. Contract Manufacturing Organization (CMO)
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Perfusion Bioreactors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.2. China Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.3. China Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.4. Japan Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.5. Japan Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.6. Japan Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.7. South Korea Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.8. South Korea Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.9. South Korea Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.10. India Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.11. India Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.12. India Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.13. Southeast Asia Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.14. Southeast Asia Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.15. Southeast Asia Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Perfusion Bioreactors Market Outlook, 2018 - 2031
7.1. Latin America Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
7.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
7.2. Latin America Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Perfusion Bioreactors for R&D
7.2.1.2. Perfusion Bioreactors for GMP
7.3. Latin America Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Biopharmaceutical Companies
7.3.1.2. Academic and Research Institutes
7.3.1.3. Contract Research Organization (CRO)
7.3.1.4. Contract Manufacturing Organization (CMO)
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Perfusion Bioreactors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.2. Brazil Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.3. Brazil Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.4. Mexico Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.5. Mexico Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.6. Mexico Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.7. Argentina Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.8. Argentina Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.9. Argentina Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.10. Rest of Latin America Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.11. Rest of Latin America Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.1.12. Rest of Latin America Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Perfusion Bioreactors Market Outlook, 2018 - 2031
8.1. Middle East & Africa Perfusion Bioreactors Market Outlook, by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Small Scale Perfusion Bioreactors (< or = 1,000 Litres)
8.1.1.2. Large Scale Perfusion Bioreactors (> 1,000 Litres)
8.2. Middle East & Africa Perfusion Bioreactors Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Perfusion Bioreactors for R&D
8.2.1.2. Perfusion Bioreactors for GMP
8.3. Middle East & Africa Perfusion Bioreactors Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Biopharmaceutical Companies
8.3.1.2. Academic and Research Institutes
8.3.1.3. Contract Research Organization (CRO)
8.3.1.4. Contract Manufacturing Organization (CMO)
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Perfusion Bioreactors Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.2. GCC Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.3. GCC Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.4. South Africa Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.5. South Africa Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.6. South Africa Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.7. Egypt Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.8. Egypt Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.9. Egypt Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.10. Nigeria Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.11. Nigeria Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.12. Nigeria Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Perfusion Bioreactors Market by Scale, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Perfusion Bioreactors Market by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Perfusion Bioreactors Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape
9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Sartorius AG
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Cell Culture Company
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Cytiva (Danaher Corporation)
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. CELLEC BIOTEK AG
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Synthecon Inc
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Getinge (Applikon Biotechnology B.V)
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Zellwerk GmbH
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Thermo Fisher Scientific Inc
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Eppendorf AG
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Infors HT
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. 3D Biotek LLC
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development

10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

Sartorius AG
Cell Culture Company
Cytiva (Danaher Corporation)
CELLEC BIOTEK AG
Synthecon Inc
Getinge (Applikon Biotechnology B.V)
Zellwerk GmbH
Thermo Fisher Scientific Inc
Eppendorf AG
Infors HT
3D Biotek LLC.

Methodology

LOADING...